ARTICLE
|
doi:10.20944/preprints202405.2030.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
disease modified treatment; multiple sclerosis; neurofilament; no evidence of disease activity; ocrelizumab; real world
Online: 30 May 2024 (13:32:26 CEST)